The global point of care diagnostics market size was valued at USD 37.03 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 6.8% from 2022 to 2030. The market is set to gain momentum in the coming years on account of the increase in funding from multiple... Read More »
May 2022The global in vitro diagnostic market size was valued at USD 111.67 billion in 2021 and is projected to grow at a compound annual growth rate (CAGR) of 0.2 % from 2022 to 2030. The growth can be attributed to the increasing adoption of IVDowing to the rise in testing due to the pandemic.... Read More »
May 2022The global hereditary testing market size was valued at USD 6.1 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 9.2% from 2022 to 2030. The expanding reproductive genetic health space is one of the key market drivers. Key players such as Natera have r... Read More »
May 2022The global malaria diagnostics market size was valued at USD 728.8 million in 2021 and is anticipated to witness a CAGR of 5.4% during the forecast period. The rising demand for malaria diagnostics and the introduction of novel diagnostic techniques are the key factors driving the market... Read More »
May 2022The global COVID-19 sample collection kits market size was valued at USD 6.48 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of (8.7)% from 2022 to 2030. SARS-CoV-2 sampling is the most critical step in the effective diagnosis of active infection.... Read More »
May 2022The global COVID-19 diagnostics market size was valued at USD 97.4 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 7.7% from 2022 to 2030. The market is driven by the rising government initiatives targeted toward the implementation of mass testin... Read More »
May 2022The global molecular diagnostics market size was valued at USD 37.04 billion in 2021 and is expected to decline at a compound annual growth rate (CAGR) of -1.6% from 2022 to 2030. The shrinking of the market can be attributed to the decline in demand for molecular COVID-19 testing during... Read More »
April 2022The global neglected tropical diseases (NTD) diagnosis market size was valued at USD 6.09 billion in 2021 and is expected to expand at a CAGR of 4.4% during the forecast period. Growing awareness of NTDs and an increasing number of initiatives undertaken by the government are anticipated... Read More »
April 2022The global blood transfusion diagnostics market size was valued at USD 3,713.7 million in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 6.6% from 2021 to 2027. This growth can be attributed to the increasing rate of approval by the U.S. FDA for blood transfusi... Read More »
November 2021The global lateral flow assays market size was valued at USD 7.2 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 4.0% from 2021 to 2028. Lateral Flow Assays (LFAs) have been developed over half a century ago, facilitating diagnosis across several appl... Read More »
November 2021The global anatomic pathology market size was valued at USD 16.06 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 10.08% from 2021 to 2028. An increase in the clinical use of biomarkers enables the pathologists to determine disease pathogenesis at the... Read More »
November 2021The global liver cancer diagnostics market size was estimated at USD 9.7 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 7.5% from 2021 to 2028. Liver cancer is one of the leading causes of cancer-related deaths around the world. According to the Amer... Read More »
November 2021The global C-reactive protein testing market size was valued at USD 5.5 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 0.3% from 2021 to 2028. Advancements in nanotechnological tools are expected to provide a lucrative perspective in designing portab... Read More »
October 2021The global liquid biopsy market size was valued at USD 7.03 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 13.5% during the forecast period. The increasing prevalence of cancer coupled with the rise in demand for fast, minimally invasive diagnostic tes... Read More »
October 2021The global biomarkers market size was valued at USD 51.18 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 14.2% from 2021 to 2028. The increasing prevalence of chronic diseases, advancements in the techniques used for the development of biomarker-based ... Read More »
September 2021The global histology and cytology market size was valued at USD 12.35 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 14.74% from 2021 to 2028. An increase in the demand for the detection of cell and tissue characteristics and a global increase in the... Read More »
September 2021The global qPCR instruments market size was valued at USD 1.07 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 3.4% from 2021 to 2028. The growing prevalence of diseases, technological advancements, and increasing demand for qPCR instruments are antic... Read More »
September 2021The global neurological biomarkers market size was valued at USD 6.1 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 12.9% from 2020 to 2028. The market growth can be attributed to a rise in the prevalence of neurological diseases, such as migraines, de... Read More »
September 2021The global infectious disease molecular diagnostics market size was valued at USD 32.4 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 3.0% from 2020 to 2028. The growth can be attributed to the growing use of molecular diagnostics in infection detect... Read More »
September 2021The global polymerase chain reaction market size was valued at USD 23.6 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 0.9% from 2021 to 2028. Some of the major factors propelling the Polymerase Chain Reaction (PCR) market are prenatal genetic testin... Read More »
September 2021The global cancer biopsy market size was valued at USD 21.26 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 11.13% from 2021 to 2027. The increasing prevalence of oncology indications, coupled with the growing geriatric population, is a major factor ... Read More »
July 2021The global chemiluminescence immunoassay market size was valued at USD 7.34 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 7.9% from 2021 to 2028. Chemiluminescence immunoassay (CLIA) solutions are widely applied in the detection of chronic diseases,... Read More »
July 2021The global lab automation market size was estimated at USD 4.8 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 8.1% from 2021 to 2028. Lab automation uses technology to substitute or streamline the manual manipulation of processes and equipment. Depen... Read More »
July 2021The U.S. cancer biopsy market size was valued at USD 6.96 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 11.0% from 2021 to 2028. The increasing popularity of image-guided needle biopsies in precision medicine applications and a rise in the adoption ... Read More »
July 2021The global COVID-19 antigen test market size was valued at USD 5.3 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 6.7% from 2021 to 2027. The COVID-19 antigen tests are gaining traction in the current scenario, as it is easy to use, patient-friendly,... Read More »
July 2021The Europe immunoassay analyzers market size was valued at USD 1.6 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 6.0% from 2021 to 2028. Immunoassays play a vital role in disease diagnosis and treatment planning. Thus, an increase in the prevalence ... Read More »
June 2021The global cellular health screening market size was valued at USD 2.22 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 6.3% from 2021 to 2028. Cellular health screening facilitates easy and rapid understanding of one’s health at a cellular level.... Read More »
June 2021The U.S. tissue diagnostics market size was valued at USD 2.07 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 3.91% from 2021 to 2028. The market is collectively driven by emerging solutions pertaining to digital tissue diagnostics, advancements in ima... Read More »
June 2021The global COVID-19 saliva screening test potential market size was valued at USD 2955.9 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 4.8% from 2021 to 2023. These estimates represent a potential market size for the COVID-19 saliva screening test i... Read More »
June 2021The global drug testing market size was valued at USD 8.1 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 4.9% from 2021 to 2028. Stringent regulations by government agencies mandating alcohol and drug testing for safety purposes and increasing initia... Read More »
May 2021The global HPV testing and Pap test market size was valued at USD 1.7 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 16.4% from 2021 to 2028. Technological advancements, increasing number of cervical cancer screening programs, and high incidence of c... Read More »
May 2021The global blood testing market size was valued at USD 73.9 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 8.3% from 2021 to 2028. Growing medical spending by the government and regulatory bodies is expected to drive the market during the forecast pe... Read More »
May 2021The global breast cancer diagnostics market size was valued at USD 3.9 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 7.0% from 2021 to 2028. The growth can be attributed to the increasing prevalence of cancer and rising government initiatives to inc... Read More »
April 2021The global infectious disease in-vitro diagnostics market size was valued at USD 56.1 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 3.9% from 2021 to 2028. The growth can be attributed to the growing geriatric population, technological advancements,... Read More »
April 2021The global kidney function tests market size was valued at USD 777.06 million in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 6.2% from 2021 to 2028. Factors, such as investments by market players, increasing R&D activities, high prevalence of kidney diseas... Read More »
February 2021The global sepsis diagnostics market size was valued at USD 627.73 million in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 9.5% from 2021 to 2027. Factors such as the high prevalence of sepsis, increasing awareness, and the introduction of technologically adv... Read More »
February 2021The global drug of abuse testing services market size was valued at USD 2.6 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 5.2% from 2021 to 2028. An increase in the consumption of alcohol and illicit drugs has led to the high growth of the market. T... Read More »
February 2021The global clinical laboratory service market size was valued at USD 200.3 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 4.7% from 2021 to 2028. The increasing burden of chronic diseases and growing demand for early diagnostic tests are expected to ... Read More »
February 2021The global rapid medical diagnostic kits market size was valued at USD 13.8 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 3.4% from 2021 to 2028. The market for rapid medical diagnostic kits is set to gain momentum in the coming years owing to the r... Read More »
February 2021The global non invasive prenatal testing market size was valued at USD 2.83 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 10.9% from 2021 to 2028. The increasing incidence of chromosomal abnormalities coupled with growing product usage in new applicat... Read More »
January 2021The global laboratory proficiency testing market size was valued at USD 1.1 billion in 2019 and is expected to expand at a compound annual growth rate (CAGR) of 7.3% from 2020 to 2027. The growth can be attributed to the increasing adoption of laboratory proficiency testing owing to stri... Read More »
January 2021The U.S. in vitro diagnostics market size was valued at USD 25.32 billion in 2019 and is expected to expand at a compound annual growth rate (CAGR) of 5.0% from 2020 to 2027. One of the major factors driving the market is increasing technological advancement in terms of accuracy, portabi... Read More »
December 2020The global in-vitro diagnostics enzymes market size was valued at USD 706.97 million in 2019 and is expected to expand at a compound annual growth rate (CAGR) of 8.97% from 2020 to 2027. Enzymes are adopted in the diagnosis of various metabolic disorders owing to their remarkable catalyt... Read More »
November 2020The global burn care centers market size was valued at USD 24.5 billion in 2019 and is expected to expand at a compound annual growth rate (CAGR) of 3.2% from 2020 to 2027. The increasing number of burn-related emergency department (ED) visits and growing hospital admissions of patients ... Read More »
November 2020The global hemato oncology testing market size was estimated at USD 2.5 billion in 2019 and is expected to expand at a compound annual growth rate (CAGR) of 14.6% from 2020 to 2027. Hemato oncology is typically referred to as the science associated with the treatment, diagnosis, and prev... Read More »
October 2020The global proteinase K market size was valued at USD 61.44 million in 2019 and is expected to expand at a compound annual growth rate (CAGR) of 7.6% from 2020 to 2027. Broad application of the enzyme in the DNA and RNA extraction for in-vitro diagnostics is anticipated to drive market g... Read More »
October 2020The global cervical dysplasia market size was valued at USD 509.2 million in 2019 and is expected to expand at a compound annual growth rate (CAGR) of 7.3% from 2020 to 2027. Cervical dysplasia occurs when there is precancerous or abnormal cell growth around or in the cervix. The presenc... Read More »
October 2020The global D-dimer testing market size was valued at USD 1.2 billion in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 4.3% from 2020 to 2027. A paradigm shift towards the demand for next-generation point-of-care D-dimer testing has driven the market. This is bec... Read More »
September 2020The global oncology companion diagnostic market size was valued at USD 2.2 billion in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 12.7% from 2020 to 2027. The evolving role of oncology companion diagnostics in the era of next-generation omics is expected to dr... Read More »
September 2020The global bacterial and viral specimen collection market size was valued at USD 13.6 billion in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 14.0% from 2020 to 2027. With an increase in demand for diagnostic testing for COVID-19, several manufacturers have ram... Read More »
September 2020The global COVID-19 detection kits market size is valued at USD 3.28 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 5.05% from 2021 to 2027. Several nations are engaged in the development of kits and apps along with tracking programs for mass test... Read More »
September 2020The global thyroid cancer diagnostics market size was valued at USD 2.4 billion in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 5.5% from 2020 to 2027. Rising prevalence of thyroid cancer and increasing emphasis on early diagnosis and treatment are factors expe... Read More »
June 2020The global liver disease diagnostics market size was valued at USD 29.3 billion in 2019 and is estimated to grow at a compound annual growth rate (CAGR) of 6.5% from 2020 to 2027. Rising prevalence of acute and chronic liver diseases is one of the major factors expected to drive the mark... Read More »
June 2020The global rare disease genetic testing market size was valued at USD 812.3 million in 2019 and is projected to register a Compound Annual Growth Rate (CAGR) of 10.9% from 2020 to 2027. Misdiagnosis can result in interventions that could later be considered inappropriate for the underlyi... Read More »
June 2020The global cannabis testing services market size was valued at USD 1.1 billion in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 15.4% from 2020 to 2027. The leading factor attributing to market growth is the growing need for cannabis testing services due to a ri... Read More »
May 2020The global prostate cancer diagnostics market size was valued at USD 2.83 billion in 2019 and is anticipated to expand at a CAGR of 13.2% during the forecast period. Increasing prevalence of prostate cancer is one of the major factors propelling the demand for diagnostic products. Accord... Read More »
February 2020The global clinical laboratory tests market size was valued at USD 176.7 billion in 2019. It is expected to register a CAGR of 7.1% over the forecast period. Increasing prevalence of chronic diseases and rising awareness among health-conscious population have fueled the growth of the ove... Read More »
February 2020The global tissue diagnostics market size was valued at USD 4.2 billion in 2019 and is expected to register a CAGR of 5.9% over the analysis period. Tissue diagnostics continues to serve as one of the gold standards for cancer diagnosis as these technologies capture the biological contex... Read More »
February 2020The global mycoplasma testing market size was valued at USD 627.16 million in 2019 and is expected to witness attractive growth over the forecast period. Increasing investments in R&D activities have contributed to huge revenue for the market. The rising introduction of novel technol... Read More »
February 2020The global dried blood spot collection cards market size was valued at USD 257.3 million in 2018 and is expected to grow at a compound annual growth rate (CAGR) of3.5% from 2019 to 2026. Dried blood spot (DBS) is a minimally invasive method used for the collection of small quantitie... Read More »
November 2019The global blood collection market size was valued at USD 8.50 billion in 2018 and is projected to register growth at a CAGR of 6.6% over the forecast period. Increasing prevalence of infectious diseases, mounting number of accident & trauma cases, and non-communicable diseases are t... Read More »
November 2019The India malaria diagnostics market size was valued at USD 18.1 million in 2018 and is expected to grow at a compound annual growth rate (CAGR) of5.4% from 2019 to 2026. In India, malaria is primarily caused by Plasmodium vivax and Plasmodium falciparum. P. vivax is mostly found in... Read More »
October 2019The U.S. influenza diagnostics market size was valued at USD 109.2 million in 2018 and is anticipated to grow at a CAGR of 5.4% during the forecast period. Influenza which is caused by the influenza virus is commonly known as flu. Influenza virus consists of three types, namely Type A, T... Read More »
October 2019The global helicobacter pylori diagnostics market size was estimated at USD 476.2 million in 2018 and is anticipated to expand at a CAGR of 6.0% over the forecast period. Increasing demand for personalized antibiotic therapy and improved cost-effectiveness of diagnosis of helicobacter py... Read More »
October 2019The global cholesterol testing products and services market size was valued at USD 14.8 billion in 2018 and is expected to witness lucrative CAGR of 7.9% over the forecast period. Growing prevalence of high cholesterol levels is expected to drive the growth. Increasing awareness regardin... Read More »
October 2019The global blood group typing market size was estimated at USD 1.64 billion in 2018 and is anticipated to expand at a CAGR of 9.7% over the forecast period. Rising use of blood group typing in prenatal testing and forensic sciences, rising number of blood transfusions due to the number o... Read More »
October 2019Heart failure POC & LOC devices market size was estimated at 45.4 million in 2018 and is projected to grow at a CAGR of 16.2% during the forecast period. Owing to miniaturization, lab-on-chip (LOC) technology exhibits high potential to improve disease diagnosis with respect to cost-e... Read More »
October 2019The global Comprehensive Metabolic Panel (CMP) Testing market size was estimated at USD 10.8 billion in 2018 and is expected to register a CAGR of 7.3% during the forecast period. Factors such as the rising prevalence of chronic diseases and emphasis on early diagnosis and treatment are ... Read More »
September 2019The global ovarian cancer diagnostics market size was estimated at USD 1.2 billion in 2018 and is expected to grow at a CAGR of 6.2% during the forecast period. Rising prevalence of ovarian cancer and increasing emphasis on early diagnosis & treatment are expected to drive market gro... Read More »
July 2019The global predictive genetic testing and consumer genomics market size was estimated at USD 3.4 billion in 2018 and is anticipated to exhibit a CAGR of 13.9% over the forecast period. The broadening horizon of predictive genetic testing as a consequence of increase in the number of... Read More »
June 2019The global sperm bank market size was estimated at USD 4.33 billion in 2018 and is projected to expand at a CAGR of 3.3% over the forecast period. Innovations in cryopreservation techniques, rising awareness, emergence of fertility tourism, and increasing access to infertility treatment ... Read More »
May 2019The global point-of-care molecular diagnostics market size was valued at USD 1.72 billion in 2018 and is anticipated to expand at a CAGR of 14.4% over the forecast period. Increased need for accurate and faster testing methods and results for the molecular tests is expected to propel the... Read More »
May 2019The global blood culture tests market size was valued at over USD 3.7 billion in 2018 and is anticipated to expand at a CAGR of 9.1% over the forecast period. Growing approval rate of new products, such as instruments and consumables for Bloodstream Infections (BSI) diagnosis, by regulat... Read More »
April 2019The global blood preparation market size was valued at USD 36.7 billion in 2018and is projected to expand at a CAGR of 5.6% from 2019 to 2026. Growing demand for blood and its components in surgical procedures is expected to be a key factor driving the market. According to the Healthcare... Read More »
April 2019The global epigenetics diagnostic market size was valued at USD 5.5 billion in 2018 and is estimated to register a CAGR of 18.8% over the forecast period. Increasing prevalence of cancer and other chronic diseases and the growing geriatric population are some of the key factors expected ... Read More »
April 2019The global Preimplantation Genetic Testing (PGT) (PGS/PGD) market size was estimated at USD 74.72 million in 2018 and is expected to expand at a CAGR of 6.2% over the forecast period. Recent technological advancements have profoundly changed thecurrent practice of prenatal screening and ... Read More »
April 2019The global In-Vitro Diagnostics quality control market size was valued at USD 905 million in 2018 and is anticipated to register a CAGR of 4.1% over the forecast period. An increasing number of accredited clinical laboratories worldwide and the presence of favorable regulatory bodies are... Read More »
March 2019The global cancer diagnostics market size was valued at USD 144. 4 billion in 2018 and is expected to register a CAGR of 7.0% over the forecast period. Growing prevalence of oncologic cases, constant technological advancements in diagnostics, and increasing demand for effective screening... Read More »
February 2019The global rabies diagnostics market size was valued at USD 1.47 billion in 2017 and is projected to expand at a CAGR of 4.1% during the forecast period. Neglected Tropical Diseases (NTDs) have afflicted several densely populated and low-resource setting regions across the globe. One suc... Read More »
February 2019The global hematology diagnostics market size was estimated at USD 5.96 billion in 2017. It is anticipated to expand at a CAGR of 5.85% over the forecast period. The factors such as increasing prevalence of blood disorders coupled with increasing awareness about these disorders, and the ... Read More »
December 2018The global capillary blood collection devices market size was valued at USD 1.15 billion in 2017. It is projected to expand at a CAGR of 5.4% during the forecast period. Rising availability of PoC diagnostics, increasing prevalence of chronic diseases, and various advantages of the produ... Read More »
December 2018The global creatinine measurement market is expected to witness significant growth over the forecast period. Creatinine is an endogenous by-product of muscle metabolism. Clinical laboratory measurement of this waste product is used for the assessment of glomerular filtration rate (GFR) t...Read More »
The global breast lesion localization methods market size was valued at USD 580.7 Million in 2017 and is projected to expand further at a CAGR of 13.3% during the forecast period. Breast cancer is the most prominent and invasive cancer; thus, increasing prevalence of it among women is ex... Read More »
November 2018The North American molecular diagnostics market size was USD 3.66 billion in 2017 and is expected to register a CAGR of 10.4% over the forecast period. Increased adoption of molecular diagnostics (MDx) for infectious diseases, coupled with advent of new cancer diagnostic solutions, is dr... Read More »
November 2018The global antinuclear antibody test market size was valued at USD 923.1 million in 2017. It is projected to expand at a CAGR of 12.5% over the forecast period. High prevalence of autoimmune disorders coupled with awareness regarding these diseases is likely to drive the market over the ... Read More »
October 2018The global disruptive behavior disorder (DBD) treatment market size was valued at USD 15.7 billion in 2017 and is expected to register a CAGR of 4.9% over the forecast period. The market is mainly driven by the growing prevalence of behavioral disorders. Disruptive behavior or externaliz... Read More »
October 2018The global women’s health diagnostics market size was valued at around USD 16.5 billion in 2017. It is expected to expand at a CAGR of 6.9% during the forecast period. Rising prevalence of infectious diseases, such as hepatitis and urinary tract infection, among women is anticipate... Read More »
September 2018The global neuroendocrine carcinoma market is expected to witness lucrative growth over the forecast period due to an increase in the incidence of neuroendocrine tumors (NETs) around the globe. This type of cancer occurs in the neuroendocrine system of the human body and produces hormone...Read More »
The global pharmaceutical sterility testing market size was valued USD 733.7 Million in 2016. It is estimated to register a CAGR of 11.8% over the forecast period. Government investments in the healthcare industry, increasing R&D activities and number of drug launches, and risin... Read More »
August 2018The North America and Europe stroke diagnostics market size was valued at USD 1.46 billion in 2016. It is anticipated to witness a CAGR of 6.2% during the forecast period. Stroke is considered as one of the leading causes of mortality and physical disability in North America and Europe. ... Read More »
July 2018The U.S. pharmaceutical sterility testing market size was estimated at USD 302.2 million in 2017. It is expected to register a CAGR of 11.3% over the forecast period. An increase in R&D activities and in the number of product approvals is anticipated to boost the market growth. In ad... Read More »
July 2018The global transplant diagnostics market size was valued at USD 500.1 million in 2016 and is likely to expand at a CAGR of 7.6% over the forecast period. An increasing number of organ transplant procedures is a major factor driving demand for diagnostics used before the procedure. The de... Read More »
June 2018The global clinical microbiology market size was valued at USD 9.1 billion in 2016 and is expected to develop at a CAGR of 6.7% over the forecast period. Constantly rising incidence of infectious diseases is driving market growth. Infectious diseases are primarily diagnosed using clinica... Read More »
June 2018The global assisted reproductive technology market size was estimated to be around USD 21 billion in 2017 and is anticipated to grow at a CAGR of 10% over the forecast period. Contributing factors to the growth are the increasing number of infertility cases due to obesity, growing stress... Read More »
May 2018The global hepatitis diagnostic test market size was valued at USD 3.9 billion in 2016 and is expected to grow at a CAGR of 6.5% over the forecast period. Rising prevalence of hepatitis diagnostics is primarily driving the growth of the global market. Data published by the World Health O... Read More »
May 2018The global blood screening market size was valued at USD 1.6 billion in 2015 and is projected to grow at a CAGR of 10.2% over the forecast period. Blood screening is a process in which donated blood is screened for various infectious diseases such as HBV, HCV, HIV1, and HIV2. High growth... Read More »
April 2018The global zika virus Testing market size was valued at USD 131.9 million in 2016. It is projected to exhibit a CAGR of 7.6% over the forecast period. Involvement of international organizations, such as UNICEF, and national governments in low-income developing regions is one of the key t... Read More »
April 2018The global influenza diagnostics market size was valued at USD 1.91 billion in 2015 and is anticipated to witness a CAGR of 6.4% during the forecast period. Influenza, which is commonly called the flu is an infectious disease of the upper respiratory system caused by the influenza virus.... Read More »
March 2018The global endocrine testing market size was valued at USD 7.04 billion in 2016 and is expected to witness a CAGR of 8.0% over the forecast period. Growing incidences of endocrine disorders such as hyperthyroidism and adrenal insufficiency is predicted to boost the demand for endocrine t... Read More »
March 2018The global primary care POC diagnostics market size was estimated at USD 6.3 billion in 2016.Rapid evolution of point-of-care testing (POCT) holds enormous potential for the growth of both primary and secondary care settings. Rapidly increasing healthcare expenditure within secondary and... Read More »
March 2018The global newborn screening market size was valued at USD 783.5 million in 2016 and is expected to grow at a CAGR of 10.6% during the forecast period. Growing neonatal population base, rising cases of congenital diseases in newborns, favorable government programs & legislations, and... Read More »
February 2018The Latin America clinical laboratory services market size was estimated at USD 14.4 billion in 2016 and is projected to expand at a CAGR of 7.5% over the forecast period. Rising burden of chronic diseases, coupled with consequent demand for diagnostic tests, is expected to serve as a hi... Read More »
February 2018The global hematologic malignancies market size was valued at USD 35.6 billion in the year 2016 with a CAGR of 10.48%. Growing incidence of blood cancer and increasing focus on the development of new treatments are expected to drive the market. Globally, blood malignancies is the fifth m... Read More »
September 2017The global Isothermal Nucleic Acid Amplification Technology market size was valued at USD 1.6 billion in 2016. Increasing demand for INAAT as a molecular testing technique and the rising prevalence of infectious diseases is expected to drive the market over the forecast period. According... Read More »
August 2017The global point of care infectious disease testing market size was estimated at USD 1.05 billion in 2016. Driven by the latest trends of consumer-centric services coupled with high demand for portable and rapid testing devices this market is expected to witness lucrative growth. Moreove... Read More »
August 2017The global Structural Heart Imaging market size was estimated at USD 10.1 billion in 2016. Global increase in incidence of Congenital Heart Diseases (CHDs) and rising government support to improve accessibility to treatments are expected to be major factors driving growth. CHDs represent... Read More »
August 2017The global Non-alcoholic steatohepatitis biomarkers market size was valued at USD 200.04 million in 2016 and is expected to witness a CAGR of 30.1% during the forecast period. The growing prevalence of chronic liver conditions is expected to upsurge demand for noninvasive ... Read More »
July 2017The global pharmacogenomics technology market size was estimated at USD 5.62 billion in 2016. Theranostics, are pioneering personalized medicine by predicting prognosis and pinpointing diagnoses down to the subtype of chronic conditions. Rising cost of healthcare coupled with new opportu... Read More »
June 2017The global vitamin D testing market size was estimated at USD 498.1 million in 2016. Global rise in geriatric population coupled with increase in chronic illnesses, such as type 2 diabetes, kidney disease, Crohn's disease, and celiac disease, is anticipated to drive the growth of the mar... Read More »
May 2017The global biopsy devices market size was estimated at USD 1.0 billion in 2016. Growing prevalence of cancer worldwide and the presence of untapped opportunities in emerging economies, especially of Asia Pacific, along with improving healthcare infrastructure in these regions are among t... Read More »
May 2017The global nucleic acid amplification testing market size was valued at USD 1.78 billion in 2015. Growing demand for advanced diagnostic measures and increasing investments for the development of new biotechnological diagnostic techniques are the key factors propelling the growth of the ... Read More »
February 2017The global autoimmune disease diagnostics market size was valued at USD 3.3 billion in the year 2015 and is estimated to reach a value of USD 5.0 billion by 2025, growing with CAGR of 4.1%. Increasing prevalence of autoimmune disorders such as type 1 diabetes in ... Read More »
February 2017The global legionella testing market size was valued at USD 160.0 million in 2015 and is expected to grow at a CAGR of 8.4% during the forecast period. The increasing incidence of Legionella-related disorders and rising awareness about their preventive management is expected to drive the... Read More »
January 2017Atrial septal defect (ASD) is a congenital heart defect in which blood flows between the atria of the heart chamber. Normally, the artria are separated by a dividing wall, the interatrial septum. If this septum is defective or absent then oxygen rich blood can flow directly from the left...Read More »
Arrhythmia is an abnormal heart rhythm. It may feel like fluttering or a brief pause. It may be so brief that it does not change your overall heart rate (the number of times per minute that your heart beats); or it can cause the heart rate to be too slow or too fast. Some arrhythmias do ...Read More »
The U.S. IVD and LDT for autoimmune diseases market was valued at USD 4.0 billion in 2015 and is expected to reach USD 4.74 billion by 2024. The market growth can be attributed to rising occurrence of autoimmune diseases & cancers and technological advances in diagnostic techniques. ... Read More »
November 2016The global cancer biological therapy market is expected to witness significant growth owing to large patient pool. There are also other factors that drive the growth of the market such as growing prevalence of several cancers, growing impact of biosimilar, continuous patent expiry of can...Read More »
The global cervical cancer diagnostic market was valued at USD 7 billion in 2015 and is projected to grow at a CAGR of 5.9% over the forecast period. Women between the age group of 20 and 60 years are usually more prone to this ailment, which is expected to increase the screening and dia... Read More »
September 2016The global tuberculosis diagnostics market was valued at USD 2.1billion in 2015 and is expected to witness a CAGR of 4.1% over the forecast period. The rising burden of tuberculosis is one of the biggest concerns among the government and healthcare agencies.... Read More »
September 2016The cardiac biomarkers market was estimated to reach USD 4.7 billion in 2015. Cardiac biomarkers refer to the substances released in the bloodstream due to heart-related damage or stress, mainly caused by insufficient blood flow. The quantification of biomarkers is employed for the diagn... Read More »
September 2016The Europe molecular diagnostics market size was valued at USD 1,750.0 million in 2015 and is expected to exhibit attractive growth over the forecast period. As a developed region, technology enhancement is enabling the European market to further grow through the development of new produ... Read More »
August 2016The Europe IVD market was valued at USD 12.51 billion in 2015. The growing base of the geriatric population in the European countries, the increasing prevalence of chronic diseases, and the rising awareness among the population for early diagnosis of life-threatening diseases are the hig... Read More »
August 2016The global critical care diagnostic (CCD) market size was estimated at USD 837.6 million in 2015. These diagnostic tests deal with the specialized care and diagnosis of life-threatening diseases occurring in patients.... Read More »
August 2016North America point of care diagnostics market was valued at USD 6.84 billion in 2015. Growing awareness for home healthcare coupled with rapid and cost-effective results provided by POC diagnostics is anticipated to propel market growth. ... Read More »
August 2016Latin America's point of care diagnostics market size was valued at USD 1.19 billion in 2015. Hospitals assisted living homecare facilities and other healthcare facilities are noted to have increased adoption rates of POC diagnostics in Latin America to provide rapid and effective diagno... Read More »
August 2016The Asia Pacific In Vitro Diagnostics market was estimated at USD 12.1 billion in 2015. The increase in number of infectious and chronic diseases, the rising awareness levels of advanced diagnostic solutions as well as technological developments are estimated to be some major factors pro... Read More »
August 2016The global Computer Aided Detection (CAD) market size was valued at USD 405.9 million in 2014. Increasing cancer prevalence and rising awareness in the population for regular health check-ups are the most significant drivers of the global CAD industry.... Read More »
August 2016The global lung cancer diagnostics market size was estimated at USD 1.63 billion in 2015. Technological advancements pertaining to tumor diagnosis contribute to market growth. The need for more efficient diagnostic systems is due to the fact that only 15% of the lung cancer cases get dia... Read More »
June 2016The global in-vitro colorectal cancer screening tests market was valued at USD 559.3 million in 2014 and is likely to grow at a CAGR of 5.2% over the forecast period.... Read More »
June 2016The global urinalysis market size was estimated at USD 1.37 billion in 2015. The magnitude of the target diseases, such as UTI, kidney diseases, and diabetes, is immense with the occurrence of millions of new cases every year. Urinalysis is used as the primary diagnostic tool for the dia... Read More »
April 2016The global cancer pain market is expected to post a healthy market growth rate during the forecast period. The steady growth of this market can be attributed to the launch of new products that specifically treat pain-related to cancer. Pain in cancer may come from compressing or infiltra...Read More »
If blood cell counts are low, then the drug given by the doctor is termed as a blood cell growth factor to stimulate blood cell production. The body normally makes blood cells with the help of a hormone produced in the kidneys, called erythropoietin (EPO). The DNA of immature blood ...Read More »
The European Real-time Polymerase Chain Reaction (qPCR) market was valued at over USD 182 million in 2014.... Read More »
February 2016Global STD diagnostics market size was valued at over USD 17 billion in 2014. An increase in patient awareness such as education campaigns and growing government initiatives are anticipated to drive market growth. ... Read More »
January 2016The global HIV diagnostics market was valued at USD 2,173.8 million in 2014 and is expected to grow at a CAGR of 9.5% over the forecast period.... Read More »
January 2016The Europe, Middle East, and Africa (EMEA) Point-of-Care (PoC) diagnostics market size was valued at USD 4,567.2 million in 2014. Growing base of geriatric population coupled with high incidence rates of chronic diseases is one of the major factors fostering the growth of EMEA PoC diagno... Read More »
January 2016The heart attack diagnostics market was estimated to reach USD 6.6 billion in 2015. Heart attack or myocardial infarction is a form of cardiovascular disease (CVD) and it occurs when oxygenated blood flow to the heart muscle is reduced or cut off, which is also termed as myocardial ische... Read More »
July 2015The global automated microbiology market is expected to grow over the forecast period owing to the increasing prevalence of pathogen induced diseases. In the recent years, identification of pathogens with the help of automated microbiology has generated huge momentum, as it helps in earl...Read More »
The global genetic disease diagnostic market is anticipated to witness growth over the forecast period, driven by rising incidences of genetic disorders that give rise to a wide variety of independent diagnostic procedures. Additionally, increasing awareness about prenatal diagnosis, ris...Read More »
The global Infectious disease diagnostics market is expected to grow during the forecast period owing to the increasing prevalence of various infectious diseases such as malaria, TB, HIV/AIDS, hepatitis, HAIs, STDs, and diarrheal diseases. The other vital drivers of this market are the g...Read More »
The global diabetes treatment market is undergoing a significant transition driven by the advent of new analytical technologies and developments in diabetes treatment. There has been a drastic increase in the incidents of diabetes worldwide, owing to the rising level of sedentary lifesty...Read More »
The global astma and COPD market is expected to witness significant growth over the forecast period. Increasing prevalence of respiratory diseases owing to the growing aging population and increasing pathogens in the environment has been the key factor driving asthma and chronic obstruct...Read More »
The rising prevalence of cardiovascular and pulmonary disorders such as arrhythmia and heart valve imbalance are the major factors driving the cardiopulmonary stress testing systems market. Furthermore, increasing incidences of lifestyle diseases coupled with heart and lung disorders are...Read More »
The global bioinformatics in IVD testing market is anticipated to witness growth over the forecast period. Factor such as the growing prevalence of cancer and other rare life-threatening disorders such as HIV, increased research and development, the cost-effectiveness of genomic sequence...Read More »
Tuberculosis is an infectious or sometimes fatal disease with mycobacteria its major cause. In common tuberculosis attacks the lungs, or even other parts of the body such as genitourinary system, lymphatic system, and central nervous system. Tuberculosis caused in lungs is known as Pulmo...Read More »
Point of care (POC) diagnosis refers to conducting diagnostic tests near the site of patient care. The Asia Pacific PoC diagnostics market is driven by four major factors namely growing geriatric population base in countries such as Japan and China, rising prevalence of target diseases, ... Read More »
April 2014The global advanced cancer diagnostics market is anticipated to grow significantly over the forecast period. Cancer or malignant neoplasm refers to a group of diseases caused by abnormal cell growth. This disease is marked by uncontrollable cell growth forming malignant tumors which inva...Read More »
The global endocrine function diagnostics market is anticipated to grow significantly over the forecast period. The endocrine system consists of a group of glands which produce and release hormones for the appropriate functioning of body functions. The most important function of these gl...Read More »
The global yersinia diagnostics market is anticipated to grow significantly over the forecast period. Yersinia is a gram-positive rod-shaped bacteria belonging to the Enterobacteriaceae family. Pathogenic species of Yersinia include Yersinia pestis, Yersinia enterocolitica and Yersinia p...Read More »
The global orthopedic extremity market is expected to witness lucrative growth over the forecast period owing to the rising global geriatric population base, coupled with increasing life expectancy rate. Rise in the incidence rate of sports injuries, the prevalence of obesity, and other ...Read More »
The global human papilloma virus testing market is expected to witness lucrative growth over the forecast period owing to the increasing prevalence of cervical cancer. The rise in the global geriatric female population is also one of the key drivers for market growth due to the presence ...Read More »
The global diagnostic electrocardiography devices market is expected to witness lucrative growth over the forecast period owing to increasing prevalence of cardiovascular diseases coupled with rising geriatric population base. Hence, the need for innovation in diagnostics for detection o...Read More »